OpenLegislation

Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances (Text with EEA relevance) (revoked)

EU Regulation No 686/2012 · Adopted 26 July 2012 · Extends to United Kingdom

Original text. legislation.gov.uk does not revise this item, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Commission Implementing Regulation (EU) No 686/2012

of 26 July 2012

allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances

(Text with EEA relevance) (revoked)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations to the whole text

Textual amendments

F1

Regulation revoked (31.12.2020) by The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), reg. 1(1), Sch. 2 Pt. 1 (with reg. 29(2)) (as amended by S.I. 2020/1376, regs. 1(4), 3(20)); 2020 c. 1, Sch. 5 para. 1(1)

Contents

  1. 1Article 1 Repealed
  2. 2Article 2 Repealed
  3. Signature
  4. Annex Repealed
  5. AAllocation of the evaluation of active substances whose approval expires by 31 December 2018 at the latest Repealed
  6. BAllocation of the evaluation of active substances whose approval expires after 31 December 2018 and not later than 31 December 2021 Repealed
  7. CAllocation of the evaluation of active substances whose approval expires after 31 December 2021 and not later than 31 December 2024 Repealed
  8. DAllocation of the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 Repealed

1F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AAllocation of the evaluation of active substances whose approval expires by 31 December 2018 at the latestF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BAllocation of the evaluation of active substances whose approval expires after 31 December 2018 and not later than 31 December 2021F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CAllocation of the evaluation of active substances whose approval expires after 31 December 2021 and not later than 31 December 2024F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DAllocation of the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .